We are live on ! Find out more
CHP

Cable Hill Partners Portfolio holdings

AUM $1.02B
1-Year Est. Return 8.59%
This Fund
S&P 500
This Quarter Est. Return
+3.39%
1 Year Est. Return
+8.59%
3 Year Est. Return
+20.32%
5 Year Est. Return
+87.59%
10 Year Est. Return
+152.97%
AUM
$230M
AUM Growth
+$12.3M
Cap. Flow
+$3.49M
Cap. Flow %
1.52%
Top 10 Hldgs %
74.62%
Holding
1,080
New
84
Increased
136
Reduced
346
Closed
127

Sector Composition

Rank Sector Weight
1 Technology 5.96%
2 Healthcare 3.63%
3 Energy 2.19%
4 Industrials 2.13%
5 Consumer Discretionary 2.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MBIO icon
626
Mustang Bio
MBIO
$4.55M
$8K ﹤0.01%
+1
New +$7.74K
MKC icon
627
McCormick & Company Non-Voting
MKC
$14.2B
$8K ﹤0.01%
154
-66
-30% -$3.29K
RF icon
628
Regions Financial
RF
$26.8B
$8K ﹤0.01%
471
-162
-26% -$2.59K
SRG
629
Seritage Growth Properties
SRG
$136M
$8K ﹤0.01%
212
VEU icon
630
Vanguard FTSE All-World ex-US ETF
VEU
$68.5B
$8K ﹤0.01%
+145
New +$7.8K
LSXMA
631
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$8K ﹤0.01%
270
-35
-11% -$1.05K
BKI
632
DELISTED
Black Knight, Inc. Common Stock
BKI
$8K ﹤0.01%
+176
New +$7.95K
ARNA
633
DELISTED
Arena Pharmaceuticals Inc
ARNA
$8K ﹤0.01%
200
ADMS
634
DELISTED
Adamas Pharmaceuticals
ADMS
$8K ﹤0.01%
+250
New +$6.98K
GHDX
635
DELISTED
Genomic Health, Inc.
GHDX
$8K ﹤0.01%
233
IMPV
636
DELISTED
Imperva, Inc.
IMPV
$8K ﹤0.01%
191
MSCC
637
DELISTED
Microsemi Corp
MSCC
$8K ﹤0.01%
155
AVXS
638
DELISTED
AveXis, Inc. Common Stock
AVXS
$8K ﹤0.01%
+73
New +$7.33K
BIVV
639
DELISTED
Bioverativ Inc. Common Stock
BIVV
$8K ﹤0.01%
137
-42
-23% -$2.3K
IMDZ
640
DELISTED
Immune Design Corp.
IMDZ
$8K ﹤0.01%
+2,000
New +$10.9K
BHVN
641
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$8K ﹤0.01%
293
AGCO icon
642
AGCO
AGCO
$7.2B
$7K ﹤0.01%
+100
New +$7.14K
ATRA icon
643
Atara Biotherapeutics
ATRA
$76.1M
$7K ﹤0.01%
16
AVB icon
644
AvalonBay Communities
AVB
$26.8B
$7K ﹤0.01%
39
-4
-9% -$726
AVNS
645
DELISTED
Avanos Medical
AVNS
$7K ﹤0.01%
159
BCO icon
646
Brink's
BCO
$4.62B
$7K ﹤0.01%
89
CLSD
647
DELISTED
Clearside Biomedical
CLSD
$7K ﹤0.01%
+67
New +$7.19K
COLM icon
648
Columbia Sportswear
COLM
$2.94B
$7K ﹤0.01%
100
CTSO icon
649
Cytosorbents Corp
CTSO
$22.6M
$7K ﹤0.01%
1,000
D icon
650
Dominion Energy
D
$59.3B
$7K ﹤0.01%
97
-2,830
-97% -$229K

Similar funds

Cable Hill Partners's Q4 2017 Portfolio in Review

As of Q4 2017, Cable Hill Partners held 1,080 positions worth $230M, up 5.7% from $218M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Cable Hill Partners's Q4 2017 filing shows 84 new, 136 increased, 346 reduced and 127 closed positions. Its largest new stake was iShares 0-5 Year Investment Grade Corporate Bond ETF: 70,119 shares worth $3.52M. The largest sale was Vanguard S&P 500 ETF, an estimated $624K.

By sector, the portfolio is most concentrated in Technology at 6% of assets, up from 5.8% a quarter earlier, followed by Healthcare and Energy.

  • Cable Hill Partners's largest Q4 2017 buy was iShares 0-5 Year Investment Grade Corporate Bond ETF: 70,119 shares worth $3.52M.
  • Cable Hill Partners added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2017, an estimated $3.89M increase.
  • Cable Hill Partners's biggest Q4 2017 reduction was Vanguard S&P 500 ETF, cutting an estimated $624K.
  • Cable Hill Partners fully exited Vanguard Short-Term Bond ETF in Q4 2017, selling an estimated $400K.
  • Cable Hill Partners's ten largest holdings make up 75% of its $230M portfolio in Q4 2017.
  • Cable Hill Partners opened 84 new positions and closed 127 in Q4 2017.
  • Cable Hill Partners's portfolio value rose 5.7% quarter-over-quarter to $230M.

Based on Cable Hill Partners's 13F filing for Q4 2017, filed 22 Feb 2018.